Search
Jun 3
ApexOnco's Madeleine Armstrong gives a recap of #ASCO24 highlights
Madeleine gives her take on data from Caribou, Summit, Daiichi Sankyo, GSK, Abbvie, and more.
Dec 10, 2023
Previewing Sunday (Day 2) of the ASH Annual Meeting with ApexOnco's Madeleine Armstrong
Madeleine Armstrong shares her thoughts on CAR-T data in lupus, the menin inhibitor class, BCMA CAR-T, and Regeneron's bi-specifics.